Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university.
During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA.
This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”.
Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endicrinology and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials.
Professor Alviggi has published extensively and has been invited to lecture at over 200 international meetings dealing with reproductive medicine and gynaecological endocrinology; he is also starter and co-founder of the Poseidon group, an international collaborative network dedicated to low prognosis patients in Assisted Reproductive Technology and vice-President of the “Società Italiana di Fertilità e Sterilità – Medicina della Riproduzione”.
Sandro C. Esteves, MD., PhD. is a reproductive urologist who specializes in treating male infertility, particularly its connection with assisted reproductive technology (ART). He is the founder and medical director of ANDROFERT, a Fertility Center based in Campinas, Brazil, dedicated to male reproductive health. He is also a Collaborating Professor of Urology at the State University of Campinas (UNICAMP), Brazil, and an Honorary Professor of Reproductive Medicine at Aarhus University, Denmark.
He obtained his MD. degree in 1990 from the Faculty of Medical Sciences of UNICAMP, Brazil. Subsequently, he completed his Urology residency at the same institution and a postdoctoral fellowship program at the Glickman’s Urological Institute at the Cleveland Clinic Foundation in the United States. He earned a master’s in Surgery from UNICAMP and a Ph.D. in Urology from the Federal University of S o Paulo (EPM-UNIFESP). Dr. Esteves has contributed to our understanding of male infertility with over 25 years of experience in clinical and academic settings. He has emphasized the limitations of basic semen analysis, the importance of assessing sperm DNA fragmentation in male infertility evaluations, and highlighted the relevance of varicocele and its treatment in enhancing male fertility prospects. He has also published extensively on his clinical experience with microsurgical treatment of infertile men, as well as on hormonal therapy for improving sperm retrieval success of men with non-obstructive azoospermia. Dr. Esteves has helped design novel stratification systems for infertile men with testicular dysfunction, for whom fertility prospects may improve after hormonal therapy, and for low prognosis infertile women undergoing ART. Dr. Esteves is a prolific author, and his research comprises over 350 published papers, numerous book chapters, and textbooks. With a Hirsch index of 71 and a citation count of around 17K, he is ranked among the top 1% of global researchers by the Science-Wide Author Databases of Standard Citation Indicators (Elsevier). Prof. Esteves plays an active role in the scientific community as a member of the Faculty Opinions in reproductive endocrinology and infertility and as a founding member of the POSEIDON group for reproductive medicine. Additionally, he holds positions as Associate Editor/Section Editor in several journals, including Human Reproduction, Andrology, Reproductive Biomedicine Online, Frontiers in Endocrinology, and the International Brazilian Journal of Urology. He also serves on the editorial boards of many scientific journals, including Nature Reviews Urology. Dr. Esteves’ clinic has been at the forefront of implementing cleanroom technology in the ART laboratory and adhering to ISO 9001 quality standards in Brazil. The ANDROFERT team is renowned for its strict quality standards and remarkable success rates in treating couples with male factor infertility. As a seasoned speaker, Dr. Esteves delivers over 50 lectures annually in Brazil and internationally. He has received multiple research grants and awards from national and international societies and currently holds the position of head of the Department of Andrology at the Brazilian Society of Human Reproduction.
In July 1998, the Fertility Center Hamburg was one of the first centres, both in Germany and worldwide, to introduce quality management, and it was certified according to the ISO 9001 and accredited for IVF laboratories (ISO 17025).
Dr Fischer’s main research interests are in the development of stimulation protocols, luteinizing hormone supplementation, and gonadotropin-releasing hormone agonist triggering, as well as further development of quality management systems in IVF centres.
He is a founding member of the European Society of Human Reproduction and Embryology (ESHRE); a founding member of the POSEIDON (Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number) group); Member of the Scientific Committee of Excellence in Medical Education (EXCEMED- formerly the Serono Symposia International Foundation) and Scientific director of Med.E.A.( Medical Education Academy)
Dr. Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic, Skive Regional Hospital, Faculty of Health Aarhus University, and Honorary professor at Faculty of Health Southern University, Odense, Denmark.
Peter Humaidan obtained his doctoral degree (DMSc) from University of Aarhus, Denmark, focusing on the role of LH during the follicular and luteal phases in controlled ovarian stimulation. During his scientific work, he has primarily focused on developing individualized ovarian stimulation and luteal phase support protocols. ICOS (individualized controlled ovarian stimulation), therefore, is an integral part of his clinical work. His research interests include GnRH agonist trigger, OHSS prediction and prevention, luteal phase support in ART, and reproductive endocrinology.
He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group”, which has published a number of articles on the use of GnRHa trigger. Moreover, he is the co-founder of the Poseidon Group, which proposed a novel stratification of the low prognosis ART patient.
Dr. Humaidan is currently deputy of the ESHRE SIG for endocrinology and has co-authored 100 plus papers (H-index 30) in peer-reviewed international journals. Peter Humaidan has a wide scientific network and is frequently invited as a speaker at international conferences.
Claus Yding Andersen is Scientific Director of Laboratory of Reproductive Biology, University Hospital of Copenhagen, Denmark and Professor of Human Reproductive Physiology within the Faculty of Health and Medical Sciences at the University of Copenhagen. He is educated as MSc (1979) and DMSc (1997).
Professor Andersen is considered one of the pioners in IVF in Denmark, is senior accredited ESHRE embryologist and have worked as a consultant in more 10 fertility clinics nationally and internationally. During the last fifteen years he has headed a national program of cryopreservation of human ovarian and testicular tissue, which is approved by the Danish Authorities. He is considered one of the pioneers in this field and continue to expand the indications for the use of ovarian tissue cryopreservation in different clinical settings.
Professor Andersen’s major research contributions have been in ovarian endocrinology, oocyte maturation, cryopreservation of gonadal tissue, human embryonic stem cells and development of new principles for ovarian stimulation including the introduction of the agonist trigger and novel approaches to luteal phase support.
He has published more than 350 peer-reviewed scientific papers plus 9 patents. He is a much-requested international lecturer and is currently giving 20-30 international lectures annually. His current H-index is 67 and has received more than 16.000 citations (Google Scholar).
He has served on the editorial board on five international journals and has reviewed papers for more than 25 international journals and six national research councils. His is currently chief editor on the Reproduction section in Frontiers in Endocrinology.
Dr Manish Banker is an infertility specialist and the Medical Director of Nova IVI Fertility Clinics, one of India’s largest group of IVF clinics with 19 clinics in 15 cities and Pulse Women’s Hospital Ahmedabad.
He has been one of the pioneers in IVF in India and started his IVF practice in 1996. His clinic in Ahmedabad is the first stand alone IVF clinic in India to receive NABH accreditation [ Small Health Care Organization ] from the Quality Council of India. He is the Course Director and PG teacher for the 2 year Fellowship in Reproductive Medicine offered by the National Board of Examinations, India and is also the Course Director of the 1 year fellowship in ART offered by Nova IVI fertility.
He has been selected for the prestigious Dr. B. C. Roy National Award for the year 2017 by the Medical Council of India in the category of “ to recognize the best talent in encouraging the development of specialties in different branches of medicine “.
He has been the President of the Indian Society for Assisted Reproduction (ISAR) and Chairman of the infertility Committee of Federation of Obstetric and Gynecological Societies of India [ FOGSI ]. He sits on the Board of Directors of Pacific Rim Society of Reproductive Medicine and Surveillance Board of IFFS. He is a Member of the Draft Committee for ART Bill of India, I. C. M. R., Ministry of Health and is the Regional representative for the International Committee for Monitoring ART [ ICMART ]. He has also been a Founder Board Member of Asia Pacific Initiative on Reproductive Endocrinology [ASPIRE] [2006 – 2008]. He was the Scientific Co Chair of IFFS 2016.
He is on the editorial board of the Journal of Human Reproductive Sciences [ JHRS ] and Clinical and Experimental and Reproductive Medicine [CERM ] and a reviewer for RBM Online.
Dr. Banker has delivered numerous orations and talks at International and National Conferences, has to his credit numerous publications and has contributed many chapters to text books. He has published the National ART Registry of India for more than 10 years.
• 2016 -Professor title, Hacettepe University, Faculty of Medicine, Department of Gynecology and Obstetrics
• 2011-2016 – Associate Professorship, Hacettepe University, Faculty of Medicine, Department of Gynecology and Obstetrics
• 2010 -McGill University, Reproductive Endocrinology and Infertility Unit, Montreal, Canada
• 2015 -Skive Regional Hospital, Fertility clinic, Skive, Denmark
• 2006 -Centro G.E.N.E.R.A, In Vitro Fertilization center, Rome, Italy
• 2004-2011 -Assistant Professor/lecturer, Hacettepe University, Faculty of Medicine, Department of Gynecology and Obstetrics
• 1999-2004 -Specialization Training, Hacettepe University, Faculty of Medicine, Department of Gynecology and Obstetrics
• 1993-1999 -Ankara University, Faculty of Medicine, master’s degree
Dr. med. Klaus Bühler (25.10.1950 – 4.4.2023)
Klaus Bühler was a founding member of the POSEIDON group ( Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number POSEIDON group) and we shall all miss him.
He was a specialist in reproductive medicine working in the Centre for Reproductive Medicine & Gynaecological Endocrinology in Stuttgart, Germany, and for the Endometriosis-Centre of the University Hospitals of Saarland – Frauenärzte am Staden – in Saarbrücken. He was specialized in Obstetrics and Gynaecology at the University of Tübingen where he also worked as a Senior Assistant until 1986. He furthermore operated as Assistant medical director at the University of Essen with special field of engagement in gynaecological endocrinology and reproductive medicine.
Klaus participated in more than 500 national and international conferences and workshops in the field of Reproductive Medicine. For Klaus, attending conferences was not only part of his obligation to stay updated in his field and to disseminate his knowledge: it was also among the more enjoyable moments to meet his friends and discuss new ideas or projects. Although some time it took him considerable effort to travel, he always glowed of having had “a good time”, full of good intentions for the future.
In addition to his clinical work, Klaus was Vice-Chairman of the German Scientific Endometriosis Research Foundation (SEF) and President of the German Dachverband for Biology and Medicine of Reproduction. He was also a member of the board of the European Society of Obstetrics and Gynaecology of German-French languages.
Since more than 20 years he was engaged in the National German IVF-Registry (Deutsches IVF-Register – DIR), the oldest IVF-registry and actually greatest with more than 1.5 million electronically documented treatment cycles. Dr. Bühler was the chairman from 2007 up to 2014. He published more than 100 scientific papers and book contributions.
He is honorary member of the Società Italiana di Medicina Perinatale and in 1989 he received the Research Award of the German Endometriosis Research Foundation.
Alessandro Conforti obtained his MD. degree in 2009. Subsequently, he attended a residency program until and specialized in Obstetrics and Gynaecology in 2015. Currently, he is a Ph.D. candidate at Federico II University, Naples, Italy, under the supervision of Prof. Carlo Alviggi.
In the first part of his career, Dr. Conforti focused his interest on Minimally Invasive and Conservative Gynecological Surgery. In 2012-2013, he worked in the Minimally Invasive Therapy Unit & Endoscopy training Center at Royal Free Hospital, London, United Kingdom, as a Clinical Research Fellow under the supervision of Dr. Adam Magos, Consultant Gynaecologist. He also worked as a Clinical Research Fellow in Fetal Medicine Unit under the guidance of Dr. Demetrios Economides, head of Fetal Medicine Unit at Royal Free Hospital.
In recent years, he has engaged in several scientific projects regarding female reproduction and oncofertility and has contributed scholarly articles in these fields published in peer-review journals as both first author and co-author. In 2010, he attended an observership program at the IVF Hammersmith Unit in London, directed by Dr. Stuart Lavery, Consultant in Gynaecology and Reproductive Medicine. During this experience, Dr. Conforti was involved in IVF cycle management, oocyte retrieval, embryo transfer, outpatient clinic and operating sessions.
Since 2016, he serves as Medical Advisor for Excemed (https://www.excemed.org/medical-advisors). He has also served as ad-hoc reviewer for international journals and has been an invited speaker at national and international meetings concerning reproductive medicine and gynaecological endocrinology.
Dr Dahan has extensive experience in studies realted to decreased ovarian reserve and advanced maternal age in IVF cycles. He has published extensively on this subject. Recent related publications include:
-Decrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverage.
Tannus S, Dahan MH., J Med Econ. 2019 Mar;22(3):252-253. doi: 10.1080/13696998.2018
-Outcomes of random start versus clomiphene citrate and gonadotropin cycles in occult premature ovarian insufficiency patients, refusing oocyte donation: a retrospective cohort study. Hatirnaz S, Basbug A, Akarsu S, Hatirnaz E, Demirci H, Dahan MH., Gynecol Endocrinol. 2018 Nov;34(11):949-954. doi: 10.1080/09513590.2018.1473361
-Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care. Tannus S, Tan J, Son WY, Dahan MH. Arch Gynecol Obstet. 2018 Apr;297(4):1037-1042
– Does ovarian reserve affect outcomes in single ideal blastocyst transfers in women less than 40 years of age? Zakhari A, Ates S, Shaulov T, Dahan MH. Arch Gynecol Obstet. 2018 Jan;297(1):233-239
Prof. Dr. Panagiotis Drakopoulos MD, PhD graduated with an excellent grade from the Faculty of Medicine (University of Athens). He completed his residency in Gynecology and Obstetrics (FMH degree) in the University Hospital of Geneva, Switzerland. He earned a Master degree (MSc) in reproductive medicine and a university diploma of statistics in clinical research from the University of Geneva.
He performed his subspecialty in reproductive medicine at the Center for reproductive medicine (CRG), UZ Brussel, Belgium. He is recognized as a subspecialist in reproductive medicine and surgery by ESHRE (European society of Human Reproduction and Embryology) and EBCOG (European Board and College of Obstetrics and Gynecology). He holds a Ph.D. in reproductive medicine from the University of Brussels (Vrije Universiteit Brussel) and he is a visiting Professor at the University since 2019. In 2021, he became Visiting Associate Professor at the University of Alexandria (Egypt).
In September 2023, he was appointed Assistant Professor and coordinator of Obstetrics and Gynecology at School of Medicine, European University of Cyprus
Prof. Dr. Drakopoulos has authored more than 100 scientific publications in international peer-reviewed journals and is a guest speaker at several international IVF conferences on an annual basis. He contributes as a reviewer to the most important journals in the field of infertility (Lancet, Human Reproduction update, Human reproduction, Fertility and Sterility, Reproductive biomedicine Online etc.).
His research focuses mainly on reproductive endocrinology and strategies for improving the outcome of patients with low prognosis (poor responders in IVF).
He remains an official clinical and scientific collaborator of the Center for Reproductive Medicine of University of Brussels (UZ Brussel). He works in private, and his medical office is found in Athens, Greece
Dr. Daniela Galliano is the Director of IVI Rome.She obtained her medical degree from the University of Torino in Italy, and completed her residency in Obstetrics and Gynecology at the Virgen de las Nieves University Hospital, Granada, Spain, where she also obtained her Ph.D. with cum laude, investigating genetic polymorphisms that influences fertility.
Michaël Grynberg is an obstetrician gynecologist specialized in reproductive medicine. After 6 months as a visiting fellow in the Department of Reproductive Medicine at Cornell University, he returned to work in France as an attending physician in the Division of Reproductive Medicine at the University Hôpital Antoine Béclère, Clamart, France. In 2011, he completed his Ph.D. on the topic of the regulation of the follicular growth and AMH production. In 2014, he became Professor of Reproductive Medicine and the Head of the Department of Reproductive Medicine & Fertility Preservation at the University Hôpital Jean Verdier, Bondy, France. Since mid-2017, he has been the head of Department of Reproductive Medicine & Fertility Preservation at the University Hôpital Antoine Béclère, Clamart, France
In addition, he is an active member of the basic research unit INSERM U 1133, Université Paris Diderot-CNRS UMR 8251. His research interests initially include the assessment of ovarian follicular status and the regulation of anti-Müllerian hormone a key peptide in the ovarian function. Over the past 5 years, he has expanded his field of research with oncofertility. Indeed, female fertility preservation has recently emerged in the field of reproductive medicine. Michaël Grynberg is a pioneer on this topic in France and has recently become the President of the French Society of Onco-Fertililty. He is also the Head of the Fertility Department within the French College of Obstetrician Gynecologists.
Prof M. Grynberg, along with his colleagues, has published over 150 peer-reviewed articles in international journals and books.
Professor Hugues was the head of Reproductive Medicine Unit at University Paris XIII.
He trained in Endocrinology and Gynaecology before being appointed as Professor of Reproductive Medicine and Development.
He succeeded in PhD in Biology of Reproduction at the University Paris XI
He was a member of many international scientific societies (ESHRE – ASRM – SGI)
His interest for the control of ovarian function and ovulation induction led him to conduct several clinical trials and to publish more than hundred articles in peer reviews.
Assistant professor of obstetrics and gynecology,Sfax university.Tunisia.(1987)
Mr Habib has completed his higher accreditation in Obstetrics and Gynecology in 1986
He works six years as a consultant in the Sfax teatching hospital .in 1988 he has his private office of gynecology and obstetrics.Since 2007 he also works in the IVF center of the polyclinic Ibn Annafis ,Sfax.Tunisia.
He has a wide experience in treating infertile couple with the first specialized fertility consultation in Tunisia (1984) .
Besides laparoscopic Surgery, his professional interests include ovarian reserve ,luteal phase support and medical treatement of uterine fibroids
He was born in 1980 in Kırcaali / Bulgaria. After completing his primary, secondary and high school education in Bursa, he entered Hacettepe University Faculty of Medicine in 1999, being among the top 50 students in the University Entrance Exam, and graduated as the top student of the faculty in 2005. Between 2005 and 2010, she received specialist training at Hacettepe University Faculty of Medicine, Department of Gynecology and Obstetrics. Between September 2010 and June 2012, she worked at Bitlis Tatvan State Hospital as a state compulsory service officer. He worked as a specialist at Bursa Zübeyde Hanım Maternity Hospital between July 2012 and November 2013. Between December 2013 and November 2014, she worked at the Gynecological Oncology Unit of Zeynep Kamil Training and Research Hospital in Istanbul, where she increased her experience in advanced gynecological endoscopic surgeries. In November 2014, she returned to Hacettepe University Faculty of Medicine, Department of Gynecology and Obstetrics as a lecturer. She completed the “Assisted Reproductive Treatment Methods Training” at Hacettepe University Faculty of Medicine between January 2015 and July 2015. He completed the “Introduction to Clinical Research and Training (ICRT)” training program given by Harvard University School of Medicine between December 2015 and May 2016 and was entitled to receive a certificate in clinical epidemiology and statistics. Between September 2016 and November 2016, Prof., the creator of the technique, on “In-Vitro Activation (IVA)”, a new method in the treatment of premature ovarian failure. Dr. From Kazuhiro Kawamura to St. Paul in Tokyo, Japan. She studied at Marianna University. She became an Associate Professor in August 2018. Between September 2018 and May 2019, with his project supported by TÜBİTAK, he conducted research on the pathophysiology of polycystic ovary syndrome in the laboratory of Professor Aaron Hsueh at Stanford University in California / United States. Special interests; i) in vitro fertilization treatments, ii) premature ovarian failure and decreased ovarian reserve, iii) preservation of fertility, iv) treatment and follow-up of endometriosis, endometrioma (chocolate cysts), v) laparoscopic and hysteroscopic surgeries, vi) polycystic ovary syndrome (PCOS). Stop. He has more than 40 articles published in international journals on these subjects.
Prof. Raoul Orvieto is a full professor of Obstetrics and Gynecology and incumbent of the Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, at the Sackler Faculty of Medicine, Tel-Aviv University, Israel. Prof. Orvieto is the director of the Division of Reproductive Endocrinology and Infertility, at the Sheba (Tel-Hashomer) Medical Center, Israel. He has been author and co-author of more than 300 publications in national and international journals. His scientific interests include various aspects of controlled ovarian hyperstimulation (COH). The role of GnRH-analogues, and specifically GnRH agonist versus antagonist in COH for IVF, pre-implantation genetic screening (PGS), triggering final follicular maturation and several aspects of ovarian hyperstimulation syndrome (OHSS): pathophysiology, prediction, prevention and its relation to the inflammatory response.
Dr. Polyzos is the Clinical and Scientific Director of the Department of Reproductive Medicine of Dexeus University Hospital in Barcelona Spain.
He is a Professor of Gynecology in the Faculty of Medicine and Pharmacy in Free University of Brussels in Belgium and a Professor of Reproductive Endocrinology in the Department of Clinical Medicine in the University of Aarhus in Denmark.
Professor Polyzos is the principal investigator in several large pioneering multinational trials and a key opinion leader in the field of Reproductive Medicine for the treatment of poor ovarian responders in IVF programs, prediction of ovarian response and premature ovarian ageing, with more than 150 invited lectures in international congresses.
He is a Section Editor in RBMO, member of the ESHRE guideline development group for ovarian stimulation and has served as an Editorial Consultant for the PIER (Physician’s Information and Education Resource) of the American College of Physicians (ACP).
Professor Polyzos has published more than 140 publications in peer-reviewed journals indexed in Pubmed with more than 2900 citations and an h index of 33 in ISI web of Science. His research interests include reproductive endocrinology, ovarian reserve markers, poor ovarian response to stimulation and genetics of premature ovarian aging.
Vicky has over 20 years’ experience in diagnosing and managing infertility. She was trained in reproductive medicine and assisted conception by Professor Kingsland at The Hewitt Centre Liverpool 1998. Subsequently, she was appointed as Lead Consultant for the Acute Gynaecology & Fertility Service at Warrington & Halton NHS FT, where she established the satellite IVF service at Halton. She was appointed Medical Director for Assisted Conception Services at The Countess of Chester Hospital (now CARE Fertility Chester) in January 2019. During this time, in addition to working for Care, she was dedicated to helping the next generation of Obstetricians & Gynaecologists achieve excellence with her role as a Training Programme Director and Less Than Full Time O&G specialty lead for Health Education North West. Since March 2022, Vicky has been delivering the role of Group Medical Director and GMC Responsible Officer for Care Fertility, which has seen her responsible for medical leadership, clinical performance and excellence for 8 clinics in the North of UK. She chairs clinical focus groups responsible for reviewing and setting group policy, and has particular interest in supporting and guiding clinical training and development, management of recurrent failure and low prognosis patients.
Ms Sesh Sunkara is a Consultant Gynaecologist and Subspecialist in Reproductive Medicine and Senior Clinical Lecturer in Reproductive Medicine at King’s College London, UK. Dr Sunkara is ranked in the TOP 0.18% of published authors worldwide on infertility by expertscape in 2022. She is an RCOG accredited Subspecialist in Reproductive Medicine and Surgery having initially specialised in general Obstetrics and Gynaecology. She is a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG). Her research work on poor responders undergoing IVF formed the basis for her Doctoral Thesis leading to her Research degree in Reproductive Medicine; Doctor of Medicine (MD) awarded by King’s College London.
In addition to her vast clinical expertise, Dr Sunkara is a highly cited author in the field of Reproductive Medicine and Infertility with several PubMed indexed peer reviewed scientific papers. She has authored of several other articles, book chapters, delivered lectures at several national and international conferences, symposia and workshops.
She is currently Associate Editor for Human Reproduction Update Journal, the highest impact factor journal in the field of Obstetrics and Gynaecology. She was previously Associate Editor of the Human Reproduction Journal from 2014 to 2018. She is on the Editorial Board of Reproductive Biology and Endocrinology Journal, Associate Editor of Gynecologic and Obstetric Investigation Journal and an expert reviewer for several other journals. She is a member of the European Society of Human Reproduction and Embryology (ESHRE) Guideline Development Group (GDG) for Ovarian Stimulation in IVF and the ESHRE Guideline on Unexplained Infertility.
Dr Sunkara is the lead for research at King’s Fertility, London.
Filippo Maria Ubaldi is Medical Doctor, Clinical Director at the GENERA Centres for Reproductive Medicine in Rome, Marostica, Umbertide and Naples, Italy. With academic degrees in Obstetrics and Gynaecology, Masters in Andrology and Reproductive Medicine, he is also intensely dedicated to educational, editorial and practitioner activities.
Co-author of 8 books on Reproductive Medicine and of 150 scientific papers on national and international scientific journals of Reproductive Medicine, his author’s H-index is 40. Editor of the treaty on Reproductive Medicine ‘Medicina della Riproduzione Umana’ published in Italy in 2010. Invited as speaker at over 300 National and International congresses on the topic of Reproductive Medicine and has been Scientific Coordinator of more than 30 congresses and courses. Member of the ESHRE Executive Committee during 2005-2009, he has been Chairman of the 26th ESHRE Annual Meeting held in Rome in June 2010.
In 2012 he achieved the national certification as full professor in Obstetrics and Gynaecology. In 2014-2015 he has been member of the technical advisory board established by the Ministry of Health on heterologous fertilization.
Alberto Vaiarelli is a Surgeon, specialist in Obstetrics and Gynaecology, PhD in Experimental Endocrinological and Metabolic Sciences with a Master’s Degree in Andrology and Reproductive Medicine and National Scientific Qualification for First Level University Professor. For more than 15 years he has been dealing with couple sterility and PMA techniques.
Medical and Scientific Coordinator of the Genera Roma center.
National Secretary of the Italian Society of Fertility-Sterility and Reproductive Medicine
Teacher in the disciplinary field of Gynecology and Reproductive Medicine in various Level I-II University Masters and Specialty courses in the Medical area.
Member of the teaching staff for second level Master’s degrees at the University of Pavia.
Professor Ariel Weissman graduated the Hadassah-Hebrew University
Medical School in 1988. In 1994 he completed his residency in Ob/Gyn at the Kaplan Medical Center, Rehovot, Israel.
Prof. Weissman then pursued a 2-year research and clinical fellowship with Prof. Bob Casper at the Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada.
Upon returning to Israel in 1998, Prof. Weissman joined the IVF unit at the Department of Ob/Gyn, Wolfson Medical Center, Holon, Tel Aviv University Sackler Faculty of Medicine where he currently holds a position of a Full Professor.
Prof. Weissman has published numerous scientific papers in peer reviewed journals and together with David Gardner PhD, Colin Howles PhD, and Zeev Shoham M.D., he published 5 editions of
“Textbook of Assisted Techniques: Laboratory and Clinical Perspectives”, which is one of the leading books in the field of ART.
Professor Hakan Yaralı, MD is the Clinical Director of Anatolia IVF Center and Professor at Hacettepe University, Ankara, Turkey. Following medical school and residency training in OB/GYN at Hacettepe University, Hakan Yaralı did his clinical fellowship at University of British Columbia, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Vancouver, Canada during 1991-1992. He has authored more than 120 articles, eight book chapters and delivered over 50 lectures worldwide. He has roles as a reviewer in top-ranked journals. He was the former president of Turkish Society of Reproductive Medicine (TSRM). He has organized several national, international meetings and preceptorship programs training clinicians from diverse countries. He is directing Anatolia IVF, which is one of the busiest IVF centers in Turkey, performing over 1600 cycles annually. His special interests are clinical IVF-all aspects.
Pedro Xavier, MD., Ph.D. is a specialist in Reproductive Medicine with over 20 years of clinical experience in the field of reproductive medicine, with a special interest in endometriosis as well as in laparoscopic surgery applied to the treatment of infertility. He led the team at São João Hospital, Porto, Portugal, that in 2015 performed the first ovarian tissue transplant in his country.
He earned his MD degree in 1992, from the Faculty of Medicine of the University of Porto, Portugal; he specialized in obstetrics and gynaecology in 2001, and gained a PhD in 2005, from the same university. His doctoral thesis explored the endometrial characteristics in patients with endometriosis.
Pedro Xavier is now the President of the Portuguese Society of Reproductive Medicine and member of the National Council for Medically Assisted Reproduction.
He authored and co-authored several articles in international peer reviewed journals in the field of reproductive medicine and has been invited to lecture at national and international meetings dealing with reproductive medicine and gynaecological endocrinology; he has also served as a reviewer for international journals in these fields.
